Latest Breaking News On - Second quarter ended december - Page 1 : comparemela.com

Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Palatin s Focus is Solely on the Development of its Melanocortin Receptor (MCR) System Pipeline PL9643 MELODY-1 Pivotal Phase 3 Study in Dry Eye Disease (DED).

United statesCarl spanaPalatin technologies incCosette pharmaceuticalsPrnewswire palatin technologies incVyleesi to cosette pharmaceuticalsMetabolic program obesityAsset sale to cosette pharmaceuticalsSexual health program male dysfunctionBremelanotide coSecurities exchangeMelanocortin receptorDry eye diseaseTopline data expectedUlcerative colitisInterim analysis expected

Intelligent Bio Solutions Inc Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights

Intelligent Bio Solutions Inc Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New zealandHarry simeonidisCheryl billsonPty ltdIntelligent bio solutionsComma communicationsAuctus management groupExchange commissionCompany asia pacificIntelligent bio solutions incRigging pty ltdSecurities exchangeCompany contactCompany onNational association of testing authoritiesCompany nasdaq

Investcorp Credit Management BDC, Inc Schedules Earnings Release for Second Quarter Ended December 31, 2023

Investcorp Credit Management BDC, Inc Schedules Earnings Release for Second Quarter Ended December 31, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Investment companyExchange commissionCm investment partnersCm finance incInvestcorp credit management bdc incSchedules earnings releaseSecond quarter ended decemberEastern timeInvestment company actInvestcorp credit management

Palatin Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

Phase 3 Pivotal Study of PL9643 in Patients with Dry Eye Disease Ongoing Patient Enrollment on Track Topline Results Currently Expected Mid-Calendar Year 2023.

New jerseyUnited statesState of new jerseyCarl spanaFosun pharmaJersey economic development authorityPalatin technologies incDilutive funding through nj economic development programPrnewswire palatin technologies incSecurities exchangeJersey technology business tax certificate transfer programDry eye disease ongoingResults currently expected mid calendarUlcerative colitis commencedInterim analysis targetedFirst half calendar year

Hollysys Automation Technologies Reports Unaudited Financial Results for the Second Quarter and the First Half Year Ended December 31, 2022

First Half of Fiscal Year 2023 Financial Highlights Total revenues were $414.8 million, an increase of 12.2% compared to the comparable prior year period..

Inner mongoliaNei mongolTechnologies ltdAutomation technologies ltdHollysys automation technologies ltdChina petroleumExchange commissionBranch of petrochinaChemical corporationHollysys automationFirst halfFiscal yearHollysys automation technologiesIndustrial automationZhongyuan oilfieldCoordination control system